medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2015-17-68-77medsovet-429Research ArticleНЕВРОЛОГИЯNEUROLOGYРасстройства сна в амбулаторной практике врачаSleep disorders in outpatient practiceПолуэктовМ. Г.PoluektovM. G.noemail@neicon.ruБорискинаЛ. М.BoriskinaL. M.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation2015301220150176877Copyright © Полуэктов М.Г., Борискина Л.М., 20152015Полуэктов М.Г., Борискина Л.М.Poluektov M.G., Boriskina L.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/429

Врачи всех специальностей сталкиваются на практике с жалобами пациентов на нарушения сна различного характера: неудовлетворенность ночным сном, дневную сонливость, бессонницу, расстройства движений во сне. Уменьшение времени сна в связи с этими расстройствами увеличивает риск развития гипертонической болезни, сахарного диабета и инфекционных заболеваний, сокращает продолжительность жизни. Наиболее часто на практике встречается инсомния, расстройства дыхания и движений во сне, поведенчески обусловленный синдром недостаточного сна. Успешная коррекция этих расстройств заметно влияет на общее состояние больных, их эмоциональный фон и течение хронических заболеваний, позволяет вести привычный для них образ жизни, оставаясь социально активными.

Doctors in all specialties are visited by patients complaining of sleep disorders of various nature: dissatisfaction with the night's sleep, daytime sleepiness, insomnia, and movement during sleep. As a result of these disorders, reduced period of sleep increases the risk of hypertension, diabetes and infectious diseases, and decreases life expectancy. In doctor's practice, the most common are insomnia, respiratory and movement disorders during sleep, behavior-based sleep deprivation. Successful management of the disorders significantly affects the overall condition of patients, their emotional state and the course of chronic diseases, allowing them to lead normal life and stay socially active.

сонинсомния апноэ во снесиндром беспокойных нограсстройства снаsleepinsomniasleep apnearestless legs syndromesleep disordersReferencesGangwisch JE, HeymsfieLd SB, Boden-ALbaLa B, Buijs RM, Kreier F, OpLer MG et aL. Sleep duration associated with mortaLity in eLderLy, but not middLe-aged, aduLts in a Large US sampLe. Sleep, 2008. 31: 1087-1096.Gangwisch JE, HeymsfieLd SB, Boden-ALbaLa B, Buijs RM, Kreier F, OpLer MG et aL. Sleep duration associated with mortaLity in eLderLy, but not middLe-aged, aduLts in a Large US sampLe. Sleep, 2008. 31: 1087-1096.GottLieb DJ, RedLine S, Nieto FJ, BaLdwin CM, Newman AB, Resnick HE et aL. Association of usuaL sLeep duration with hypertension: the SLeep Heart HeaLth Study. Sleep, 2006. 29: 1009-1014.GottLieb DJ, RedLine S, Nieto FJ, BaLdwin CM, Newman AB, Resnick HE et aL. Association of usuaL sLeep duration with hypertension: the SLeep Heart HeaLth Study. Sleep, 2006. 29: 1009-1014.GottLieb DJ, Punjabi NM, Newman AB, Resnick HE, RedLine S, BaLdwin CM et aL. Association of sLeep time with diabetes meLLitus and impaired gLucose toLerance. Archives of Internal Medicine, 2005. 165: 863-868.GottLieb DJ, Punjabi NM, Newman AB, Resnick HE, RedLine S, BaLdwin CM et aL. Association of sLeep time with diabetes meLLitus and impaired gLucose toLerance. Archives of Internal Medicine, 2005. 165: 863-868.Knutson KL, Van Cauter E. Associations between sLeep Loss and increased risk of obesity and diabetes. Annals of the New York Academy of Sciences, 2008. 1129: 287-304.Knutson KL, Van Cauter E. Associations between sLeep Loss and increased risk of obesity and diabetes. Annals of the New York Academy of Sciences, 2008. 1129: 287-304.SpiegeL K, LeprouLt R, Van Cauter E. Impact of sLeep debt on metaboLic and endocrine function. Lancet, 1999. 354(9188): 1435-1439.SpiegeL K, LeprouLt R, Van Cauter E. Impact of sLeep debt on metaboLic and endocrine function. Lancet, 1999. 354(9188): 1435-1439.Irwin M, McCLintick J, CostLow C, Fortner M, White J, GiLLin JC et aL. PartiaL night sLeep deprivation reduces naturaL kiLLer and ceLLuLar immune responses in humans. The Journal of the Federation of American Societies for Experimental Biology, 1996. 10(5): 643-653.Irwin M, McCLintick J, CostLow C, Fortner M, White J, GiLLin JC et aL. PartiaL night sLeep deprivation reduces naturaL kiLLer and ceLLuLar immune responses in humans. The Journal of the Federation of American Societies for Experimental Biology, 1996. 10(5): 643-653.Shearer WT, Reuben JM, MuLLington JM, Price NJ, Lee BN, Smith EO et aL. SoLubLe TNF aLpha receptor 1 and IL-6 pLasma LeveLs in humans subjected to the sLeep deprivation modeL of spacefLight. Journal of Allergy and Clinical Immunology, 2001. 107(1): 165-170.Shearer WT, Reuben JM, MuLLington JM, Price NJ, Lee BN, Smith EO et aL. SoLubLe TNF aLpha receptor 1 and IL-6 pLasma LeveLs in humans subjected to the sLeep deprivation modeL of spacefLight. Journal of Allergy and Clinical Immunology, 2001. 107(1): 165-170.Redwine L, Hauger RL, GiLLin JC, Irwin M. Effects of sLeep and sLeep deprivation on interLeu-kin-6, growth hormone, cortisoL, and meLatonin LeveLs in humans. Journal of Clinical Endocrinology and Metabolism, 2000. 85(10): 3597-3603.Redwine L, Hauger RL, GiLLin JC, Irwin M. Effects of sLeep and sLeep deprivation on interLeu-kin-6, growth hormone, cortisoL, and meLatonin LeveLs in humans. Journal of Clinical Endocrinology and Metabolism, 2000. 85(10): 3597-3603.Kripke DF, GarfinkeL L, Wingard DL, KLauber MR, MarLer MR. MortaLity associated with sLeep duration and insomnia. Archives of General Psychiatry, 2002. 59(2): 131-136.Kripke DF, GarfinkeL L, Wingard DL, KLauber MR, MarLer MR. MortaLity associated with sLeep duration and insomnia. Archives of General Psychiatry, 2002. 59(2): 131-136.Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, MaLhotra A et aL. A prospective study of sLeep duration and coronary heart disease in women. Archives of Internal Medicine, 2003. 163(2): 205-209.Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, MaLhotra A et aL. A prospective study of sLeep duration and coronary heart disease in women. Archives of Internal Medicine, 2003. 163(2): 205-209.Liu Y, Tanaka H. Overtime work, insufficient sLeep, and risk of non-fataL acute myocardiaL infarction in Japanese men. Journal of Occupational and Environmental Medicine, 2002. 59: 447-451.Liu Y, Tanaka H. Overtime work, insufficient sLeep, and risk of non-fataL acute myocardiaL infarction in Japanese men. Journal of Occupational and Environmental Medicine, 2002. 59: 447-451.van Leeuwen WM, Lehto M, KarisoLa P, LindhoLm H, SaLLinen M, Harma M et aL. SLeep restriction increases the risk of deveLoping cardiovascuLar diseases by augmenting proinfLam-matory responses through IL-17 and CRP. PLoS One, 2009. 4(2): e4589.van Leeuwen WM, Lehto M, KarisoLa P, LindhoLm H, SaLLinen M, Harma M et aL. SLeep restriction increases the risk of deveLoping cardiovascuLar diseases by augmenting proinfLam-matory responses through IL-17 and CRP. PLoS One, 2009. 4(2): e4589.Левин Я.И., Полуэктов М.П (ред.) Сомнология и медицина сна. Избранные лекции. М.: Медфорум, 2013. 430 с.Левин Я.И., Полуэктов М.П (ред.) Сомнология и медицина сна. Избранные лекции. М.: Медфорум, 2013. 430 с.American Academy of SLeep Medicine: InternationaL cLassification of sLeep disorders, 3rd ed.: Diagnostic and coding manuaL. Darien, IL: American Academy of SLeep Medicine, 2014.American Academy of SLeep Medicine: InternationaL cLassification of sLeep disorders, 3rd ed.: Diagnostic and coding manuaL. Darien, IL: American Academy of SLeep Medicine, 2014.Saper C, FuLLer PM, Pedersen NP, Lu J, ScammeLl TE. SLeep state switching. Neuron, 2010. 68(6): 1023-42.Saper C, FuLLer PM, Pedersen NP, Lu J, ScammeLl TE. SLeep state switching. Neuron, 2010. 68(6): 1023-42.Валокордин®-Доксиламин (VaLocordin®-DoxyLamine). Инструкция по применению, противопоказания, состав и цена. Электронный документ: http//www.rLsnet.ru/ tn_index_id_46893.htm по состоянию на 22.10.2015.Валокордин®-Доксиламин (VaLocordin®-DoxyLamine). Инструкция по применению, противопоказания, состав и цена. Электронный документ: http//www.rLsnet.ru/ tn_index_id_46893.htm по состоянию на 22.10.2015.Лишневская В.Ю. Инсомния у больных пожилого возраста с артериальной гипертензией. Новости медицины фармации, 2007. 16 (222): 30-31.Лишневская В.Ю. Инсомния у больных пожилого возраста с артериальной гипертензией. Новости медицины фармации, 2007. 16 (222): 30-31.Parra O, Sanchez-ArmengoL A, Bonnin M, Arboix A, Campos-Rodriguez F, Perez-RoncheL J et aL. EarLy treatment of obstructive apnoea and stroke outcome: a randomised controLLed triaL. European Respiratory Journal, 2011. 37(5): 1128-1136.Parra O, Sanchez-ArmengoL A, Bonnin M, Arboix A, Campos-Rodriguez F, Perez-RoncheL J et aL. EarLy treatment of obstructive apnoea and stroke outcome: a randomised controLLed triaL. European Respiratory Journal, 2011. 37(5): 1128-1136.

The authors declare that there are no conflicts of interest present.